Real-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines - Vaccine Advisor

Real-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines  Vaccine Advisor

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-1...

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination  Nature

COVID-19 Omicron XBB.1.5 | virus subvariant - Britannica

COVID-19 Omicron XBB.1.5 | virus subvariant  Britannica

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies | mBio  ASM Journals

Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell ...

Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis  The Lancet

XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among a...

XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants  Frontiers

BNT162b2 XBB.1.5-Adapted Single Dose Vaccine Uptake and Effectiveness in Children Aged 5-17 Years...

BNT162b2 XBB.1.5-Adapted Single Dose Vaccine Uptake and Effectiveness in Children Aged 5-17 Years in California and Louisiana  The Journal of Pediatrics

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance - News-Medical

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance  News-Medical

Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...

Genomic Surveillance for SARS-CoV-2 Variants: ...  Centers for Disease Control and Prevention | CDC (.gov)

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke University School of Medicine

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection  Nature

The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-r...

The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells  Frontiers

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study  Nature

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 su...

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages  Nature

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies  Nature

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines  Nature

Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature

Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant  Nature

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System  Nature

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strai...

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters  Nature

Neutralizing antibody responses to three XBB protein vaccines in older adults - Nature

Neutralizing antibody responses to three XBB protein vaccines in older adults  Nature

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1  Nature

Evaluation of broad-spectrum protection by novel mRNA vaccines against SARS-CoV-2 variants (Delta...

Evaluation of broad-spectrum protection by novel mRNA vaccines against SARS-CoV-2 variants (Delta, Omicron-BA.5, XBB-EG.5) in the golden hamster model  Virology Journal

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials  Nature

Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...

Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study  The Lancet

Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity - Nature

Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity  Nature

SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4 - Frontiers

SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4  Frontiers

The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduce...

The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14  ASM Journals

A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage...

A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants  Nature

Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, Octobe...

Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform  medRxiv

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 w...

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings  EurekAlert!

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids  CIDRAP

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to...

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform - eClinicalMedicine  The Lancet

Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine booste...

Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation  Frontiers

Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice - Frontiers

Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice  Frontiers

Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodi...

Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients  ScienceDirect.com

S. Korean health authorities reject baseless 'Omicron surge' warning - AFP Fact Check

S. Korean health authorities reject baseless 'Omicron surge' warning  AFP Fact Check

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation  Nature

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmis...

Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement  Frontiers

Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vacci...

Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections  Nature

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity - Nature

Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity  Nature

Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine a...

Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-cont  ScienceDirect.com

(PDF) Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among...

(PDF) Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trial  researchgate.net

Full article: Health outcomes and economic burden among patients with a COVID-19-associated hospi...

Full article: Health outcomes and economic burden among patients with a COVID-19-associated hospitalization in the United States during the predominance of the XBB and JN.1 omicron lineages  Taylor & Francis Online: Peer-reviewed Journals

The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on...

The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on the evolution of SARS-CoV-2  medRxiv

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XB...

Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants  Nature

(PDF) SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4+ T cell resp...

(PDF) SARS-CoV-2 XBB.1.5 infects wild-type C57BL/6 mice and induces a protective CD4+ T cell response required for viral clearance  researchgate.net

XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight - Seeking Alpha

XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight  Seeking Alpha

Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syr...

Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters  ASM Journals

(PDF) Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among...

(PDF) Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5-80 years in India: a phase 3, single-blind, randomised controlled trial  researchgate.net

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine bo...

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster  ScienceDirect.com

Conformational Dynamics and Binding Interactions of SARS-CoV-2 Spike Protein Variants: Omicron, X...

Conformational Dynamics and Binding Interactions of SARS-CoV-2 Spike Protein Variants: Omicron, XBB.1.9.2, and EG.5  ACS Publications

Pfizer and BioNTech's Omicron KP.2 Vaccine Approval: A Strategic Win in the mRNA Era - AInvest

Pfizer and BioNTech's Omicron KP.2 Vaccine Approval: A Strategic Win in the mRNA Era  AInvest

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants - ASM J...

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants  ASM Journals

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study  The Lancet

XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association

XBB.1.5 Omicron subvariant: Questions patients may have  American Medical Association

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)

TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates  Nature

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada:...

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up  medRxiv

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the abse...

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology  Nature

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...

What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB ...

Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection  Frontiers

Here’s what we know about the new Omicron variant XBB.1.5 - Gavi, the Vaccine Alliance

Here’s what we know about the new Omicron variant XBB.1.5  Gavi, the Vaccine Alliance

Wastewater surveillance in post-omicron silent phase uncovers silent waves and cryptic transmissi...

Wastewater surveillance in post-omicron silent phase uncovers silent waves and cryptic transmission of SARS-CoV-2 variants; a yearlong study in Western India  ScienceDirect.com

What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS

What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant  PBS

Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network

Rising cases of COVID-19 variant, XBB.1.5  Mayo Clinic News Network

Durability of XBB.1.5 Vaccines against Omicron Subvariants - New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants  New England Journal of Medicine

Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in h...

Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans  ScienceDirect.com

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - Centers for Disease Control and P...

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ...  Centers for Disease Control and Prevention | CDC (.gov)

SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts - News24

SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts  News24

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variant...

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants  ScienceDirect.com

XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video - Ameri...

XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video  American Medical Association

Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...

Interim Effectiveness of Updated 2023–2024 ...  Centers for Disease Control and Prevention | CDC (.gov)

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant  Nature

Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine

Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know  Yale Medicine

Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...

Interim Effectiveness of Updated 2023–2024 ...  Centers for Disease Control and Prevention | CDC (.gov)

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants  Nature

XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant - University of California - Dav...

XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant  University of California - Davis Health

WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries - CIDRAP

WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries  CIDRAP

The Updated COVID Vaccines Are Here: 9 Things to Know - Yale Medicine

The Updated COVID Vaccines Are Here: 9 Things to Know  Yale Medicine

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of...

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases  Frontiers

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion  Nature

Omicron XBB.1.5 variant expands US dominance - CIDRAP

Omicron XBB.1.5 variant expands US dominance  CIDRAP

SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recogn...

SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition  ScienceDirect.com

Covid variant 'Arcturus' is spreading: What to know about XBB.1.16 - NBC News

Covid variant 'Arcturus' is spreading: What to know about XBB.1.16  NBC News

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - New England J...

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  New England Journal of Medicine

Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology

Updated COVID-19 Boosters and XBB.1.5: What You Need to Know  American Society for Microbiology

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants | Scientific Reports  Nature

How dangerous is the new variant of Covid? - Dhaka Tribune

How dangerous is the new variant of Covid?  Dhaka Tribune

The rise of variant XBB.1.5, and more — this week’s best science graphics - Nature

The rise of variant XBB.1.5, and more — this week’s best science graphics  Nature

How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst ex...

How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst explains  CNN

US XBB.1.5 levels continue steady rise - CIDRAP

US XBB.1.5 levels continue steady rise  CIDRAP

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden - The ...

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden  The Lancet

Continued evasion of neutralizing antibody response by Omicron XBB.1.16 - ScienceDirect.com

Continued evasion of neutralizing antibody response by Omicron XBB.1.16  ScienceDirect.com

XBB.1.5 finds ‘evolutionary sweet spot,’ becomes most transmissible subvariant - Healio

XBB.1.5 finds ‘evolutionary sweet spot,’ becomes most transmissible subvariant  Healio

Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US - CNN

Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US  CNN

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - New England Journa...

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster  New England Journal of Medicine

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious  Scientific American

Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID...

Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster  ScienceDirect.com

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency - CIDRAP

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency  CIDRAP

XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP

XBB booster offers protection against JN.1 infections, hospital cases, new data show  CIDRAP